Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.3M
1M shares
52-week range
$1.77 – $127.20
0% from low
Sector
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
CS
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
www.ispecimen.comNo one on the platform currently holds ISPC.
No tracked institution reports a position in ISPC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-04-28 | 1-for-40reverse |
| 2024-09-16 | 1-for-20reverse |
No one on the platform has traded ISPC yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $38M | +205.7% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-01 | $-152.00 | $-23.60 | +84.5% |
| 2025-11-17 | $-3.80 | $-0.48 | +87.4% |
| 2025-08-14 | $-3.80 | $-0.42 | +88.9% |
| 2025-05-19 | $-4.40 | $-0.71 | +83.9% |
| 2025-04-14 | $-4.00 | $-6.28 | -57.0% |
| 2024-11-07 | $-3.80 | $-2.10 | +44.7% |
| 2024-08-06 | $-5.60 | $-3.80 | +32.1% |
| $4M |
| — |
| HSCSHeartSciences Inc. | $2.06 | +3.00% | $4M | — |
| NDRAENDRA Life Sciences Inc. | $4.47 | +0.00% | $6M | — |
Source: Financial Modeling Prep · peers by sector/industry
$EBS $VRAX $ISPC $CODX $AEMD Get ready for YeaR of the ViRuS 🦠 https://share.google/yHFYfMR3ycFbJw0Fh
View on StockTwits ↗iSpecimen Inc. $ISPC (8h) Bullish Flow: Steady accumulation building at low-float base levels as price flattens out and reclaims local moving average support, setting up a sharp volatility expansion off absolute historical lows. 🐂 💧 Bull Key Level: $2.40 (Breakout confirmation trigger to clear local pivot high and ignite acceleration into overhead volume gap) 🐂 🔥 Bear Key Level: $1.78 (Absolute structural support floor and risk-off boundary) 🐻 ⚠️ Targets: $3.00 / $3.50 💰 🍻 Why: Price action on the 8h frame is forming a multi-week bottoming consolidation pattern following a steep markdown phase. Holding firmly above the $2.00 support shelf keeps the runway open for a momentum sweep toward the primary high-volume resistance nodes. #ispc #smallcaps #pennystocks #stocktrading #hovdid
View on StockTwits ↗$CODX $VRAX $AEMD $EBS $ISPC https://www.science.org/content/article/smallpox-may-be-gone-u-s-should-better-prepare-its-return-report-says
View on StockTwits ↗$ISPC E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen https://marketwirenews.com/stock/ispc/news/e-f-hutton-co-acts-as-acts-as-exclusive-placement-ag-8483566068678683.html?utm_source=stocktwits
View on StockTwits ↗$ISPC 🚀🧬 $ISPC iSpecimen — a hidden gem in precision medicine? AI in biotech needs one thing: real biological data. iSpecimen connects researchers, pharma, hospitals & biobanks through a digital biospecimen marketplace — helping accelerate drug discovery, biomarkers, and diagnostics. 🔥 Why watch $ISPC: ✅ Cancer + neuro disease specimen access ✅ AI + biotech + precision medicine tailwinds ✅ “Picks & shovels” play for future healthcare innovation The world needs better access to human samples. iSpecimen is building the bridge. 👀 $ISPC #Biotech #AI #PrecisionMedicine #CancerResearch
View on StockTwits ↗$SPCX $ONCO $TRNR $ISPC $PPCB It is happening now. Load up and Hold strong
View on StockTwits ↗$ISPC great set up .. announcing offering and opens lower and goes green this clears $2 look out! $CLRO and $ASPN peeps have a 👀
View on StockTwits ↗$SPCX $ONCO $TRNR $ISPC $PPCB Monster news now target $20 ++++++ https://finance.yahoo.com/technology/ai/articles/onconetix-acquisition-target-realbotix-secures-123000606.html
View on StockTwits ↗$ISPC pricing a small public offering. Dilution risk is real when the market cap is this tiny. Five million bucks isn't game-changing. But it keeps the lights on.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.